{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:27:55Z","timestamp":1790224075786,"version":"4.1.0"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.tvjl.2021.105648","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T23:34:24Z","timestamp":1614123264000},"page":"105648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Interferon therapies in small animals"],"prefix":"10.1016","volume":"271","author":[{"given":"Ralf S.","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2021.105648_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074897","article-title":"Anti-tumor effect of adipose tissue derived-mesenchymal stem cells expressing interferon-beta and treatment with cisplatin in a xenograft mouse model for canine melanoma","volume":"8","author":"Ahn","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tvjl.2021.105648_bib0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tvjl.2011.08.017","article-title":"Canine periodontitis: the dog as an important model for periodontal studies","volume":"191","author":"Albuquerque","year":"2012","journal-title":"Veterinary Journal"},{"key":"10.1016\/j.tvjl.2021.105648_bib0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1743-422X-9-6","article-title":"Antiviral activity of the EB peptide against zoonotic poxviruses","volume":"9","author":"Altmann","year":"2012","journal-title":"Virology Journal"},{"key":"10.1016\/j.tvjl.2021.105648_bib0020","first-page":"55","article-title":"Feline cowpoxvirus infections in Germany: clinical and epidemiological aspects","volume":"126","author":"Appl","year":"2013","journal-title":"Berliner und M\u00fcnchner Tierarztliche Wochenschrift"},{"key":"10.1016\/j.tvjl.2021.105648_bib0025","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.4049\/jimmunol.170.4.1995","article-title":"NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major","volume":"170","author":"Artis","year":"2003","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vetimm.2004.01.012","article-title":"The biological effects of five feline IFN-alpha subtypes","volume":"99","author":"Baldwin","year":"2004","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0035","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.tvjl.2014.09.030","article-title":"Limited efficacy of topical recombinant feline interferon-omega for treatment of cats with acute upper respiratory viral disease","volume":"202","author":"Ballin","year":"2014","journal-title":"The Veterinary Journal"},{"key":"10.1016\/j.tvjl.2021.105648_bib0040","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/jir.1997.17.625","article-title":"Low-dose oral type I interferons reduce early virus replication of murine cytomegalovirus in vivo","volume":"17","author":"Beilharz","year":"1997","journal-title":"Journal of Interferon and Cytokine Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0045","first-page":"369","article-title":"Relevance of feline calicivirus, feline immunodeficiency virus, feline leukemia virus, feline herpesvirus and Bartonella henselae in cats with chronic gingivostomatitis","volume":"123","author":"Belgard","year":"2010","journal-title":"Berliner und M\u00fcnchner Tierarztliche Wochenschrift"},{"key":"10.1016\/j.tvjl.2021.105648_bib0050","first-page":"476","article-title":"Der Einsatz Von Baypamun HKO in der mammatumorbehandlung der H\u00fcndin","volume":"49","author":"Berg","year":"1994","journal-title":"Tier\u00e4rztliche Umschau"},{"key":"10.1016\/j.tvjl.2021.105648_bib0055","first-page":"258","article-title":"Interferonisierung: eine neue m\u00f6glichkeit der bek\u00e4mpfung des infekti\u00f6sen welpensterbens","volume":"20","author":"Bibrack","year":"1975","journal-title":"Kleintierpraxis"},{"key":"10.1016\/j.tvjl.2021.105648_bib0060","first-page":"261","article-title":"Placebo-controlled double-blind study on the efficacy of a paramunity inducer in the treatment of naturally FeLV-infected cats","volume":"25","author":"Block","year":"1997","journal-title":"Tier\u00e4rztliche Praxis"},{"key":"10.1016\/j.tvjl.2021.105648_bib0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/vr.113.9.201","article-title":"The \u2018fading puppy complex\u2019: an assessment of a paraimmunity inducer as a means of control","volume":"113","author":"Blunden","year":"1983","journal-title":"Veterinary Record"},{"key":"10.1016\/j.tvjl.2021.105648_bib0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-3164.2009.00848.x","article-title":"The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study","volume":"20","author":"Carlotti","year":"2009","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0075","first-page":"283","article-title":"In-vitro antiviral efficacy of ribavirin and interferon-alpha against canine distemper virus","volume":"78","author":"Carvalho","year":"2014","journal-title":"Canadian Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0080","doi-asserted-by":"crossref","first-page":"463","DOI":"10.14740\/jocmr4241","article-title":"Exploring repurposing potential of existing drugs in the management of COVID-19 epidemic: a critical review","volume":"12","author":"Chakraborty","year":"2020","journal-title":"Journal of Clinical Medicine Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1099\/vir.0.016485-0","article-title":"Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene","volume":"91","author":"Chang","year":"2010","journal-title":"Journal of General Virology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.1993.13.313","article-title":"Cloning and structural analysis of four genes encoding interferon-omega in rabbit","volume":"13","author":"Charlier","year":"1993","journal-title":"Journal of Interferon Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0095","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/vr.120.16.391","article-title":"Effect of human alpha-hybrid interferon on the course of feline viral rhinotracheitis","volume":"120","author":"Cocker","year":"1987","journal-title":"Veterinary Record"},{"key":"10.1016\/j.tvjl.2021.105648_bib0100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.vetmic.2007.03.008","article-title":"Effect of type I interferons on the expression of feline leukaemia virus","volume":"123","author":"Collado","year":"2007","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0105","first-page":"513","article-title":"Oral use of human alpha interferon in cats","volume":"7","author":"Cummins","year":"1988","journal-title":"Journal of Biological Response Modifiers"},{"key":"10.1016\/j.tvjl.2021.105648_bib0110","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1089\/107999099313352","article-title":"Oral use of interferon","volume":"19","author":"Cummins","year":"1999","journal-title":"Journal of Interferon and Cytokine Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/vr.152.4.105","article-title":"Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial","volume":"152","author":"de Mari","year":"2003","journal-title":"Veterinary Record"},{"key":"10.1016\/j.tvjl.2021.105648_bib0120","first-page":"477","article-title":"Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV\/feline immunodeficiency virus (FIV)-coinfected symptomatic cats","volume":"18","author":"de Mari","year":"2004","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2021.105648_bib0125","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1089\/jir.2012.0130","article-title":"Genomic analysis and mRNA expression of equine type I interferon genes","volume":"33","author":"Detournay","year":"2013","journal-title":"Journal of Interferon and Cytokine Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.vetimm.2011.06.008","article-title":"Use of recombinant interferon omega in feline retrovirosis: from theory to practice","volume":"143","author":"Domenech","year":"2011","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0135","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ptr.5290","article-title":"Yu Ping Feng San, an ancient chinese herbal decoction, induces gene expression of anti-viral proteins and inhibits neuraminidase activity","volume":"29","author":"Du","year":"2015","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/107999099314306","article-title":"Oromucosal interferon therapy: pharmacokinetics and pharmacodynamics","volume":"19","author":"Eid","year":"1999","journal-title":"Journal of Interferon and Cytokine Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aan5357","article-title":"Type III interferon is a critical regulator of innate antifungal immunity","volume":"2","author":"Espinosa","year":"2017","journal-title":"Science Immunology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0150","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/1098612X15596199","article-title":"Evaluation of intranasal vaccine administration and high-dose interferon-alpha2b therapy for treatment of chronic upper respiratory tract infections in shelter cats","volume":"18","author":"Fenimore","year":"2016","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2021.105648_bib0155","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.rvsc.2010.12.012","article-title":"Cytokine-enhanced vaccine and interferon-beta plus suicide gene as combined therapy for spontaneous canine sarcomas","volume":"91","author":"Finocchiaro","year":"2011","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0160","first-page":"5","article-title":"Combination of suicide and cytokine gene therapies as surgery adjuvant for canine mammary carcinoma","author":"Finocchiaro","year":"2018","journal-title":"Veterinary Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0165","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41434-019-0066-7","article-title":"Combination of cytokine-enhanced vaccine and chemo-gene therapy as surgery adjuvant treatments for spontaneous canine melanoma","volume":"26","author":"Finocchiaro","year":"2019","journal-title":"Gene Therapy"},{"key":"10.1016\/j.tvjl.2021.105648_bib0170","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1128\/AAC.28.5.698","article-title":"Susceptibility of feline herpesvirus 1 and a feline calicivirus to feline interferon and recombinant human leukocyte interferons","volume":"28","author":"Fulton","year":"1985","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2021.105648_bib0175","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.prevetmed.2009.10.012","article-title":"Factors influencing heartworm, flea, and tick preventative use in patients presenting to a veterinary teaching hospital","volume":"93","author":"Gates","year":"2010","journal-title":"Preventive Veterinary Medicine"},{"key":"10.1016\/j.tvjl.2021.105648_bib0180","first-page":"486","article-title":"Production of virus-induced and mitogen-induced interferons by canine cells","volume":"35","author":"Georgadze","year":"1990","journal-title":"Voprosy virusologii"},{"key":"10.1016\/j.tvjl.2021.105648_bib0185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/eji.200838311","article-title":"Anti-retroviral effects of type I IFN subtypes in vivo","volume":"39","author":"Gerlach","year":"2009","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0190","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/jir.1985.5.403","article-title":"Pharmacokinetics of recombinant leukocyte A interferon following various routes and modes of administration to the dog","volume":"5","author":"Gibson","year":"1985","journal-title":"Journal of Interferon Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0195","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.rvsc.2012.09.025","article-title":"Relevance of feline interferon omega for clinical improvement and reduction of concurrent viral excretion in retrovirus infected cats from a rescue shelter","author":"Gil","year":"2013","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rvsc.2013.11.007","article-title":"Oral recombinant feline interferon-omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation","volume":"96","author":"Gil","year":"2014","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0205","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/107999099313433","article-title":"Low-dose oral administration of interferon-alpha for the treatment of immune-mediated keratoconjunctivitis sicca in dogs","volume":"19","author":"Gilger","year":"1999","journal-title":"Journal of Interferon and Cytokine Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0210","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/v11090845","article-title":"Follow-up of viral parameters in FeLV- or FIV-naturally infected cats treated orally with low doses of human interferon alpha","volume":"11","author":"Gomez-Lucia","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.tvjl.2021.105648_bib0215","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3390\/ani10091464","article-title":"Clinical and hematological follow-up of long-term oral therapy with type-I interferon in cats naturally infected with feline leukemia virus or feline immunodeficiency virus","volume":"10","author":"Gomez-Lucia","year":"2020","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.tvjl.2021.105648_bib0220","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tim.2013.04.004","article-title":"Innate immune detection of microbial nucleic acids","volume":"21","author":"Gurtler","year":"2013","journal-title":"Trends in Microbiology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-3164.2007.00556.x","article-title":"Feline herpes dermatitis treated with interferon omega","volume":"18","author":"Gutzwiller","year":"2007","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0230","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1463-5224.2007.00550.x","article-title":"Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats","volume":"10","author":"Haid","year":"2007","journal-title":"Veterinary Ophthalmology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0235","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.micinf.2007.09.010","article-title":"The Mx GTPase family of interferon-induced antiviral proteins","volume":"9","author":"Haller","year":"2007","journal-title":"Microbes and Infection"},{"key":"10.1016\/j.tvjl.2021.105648_bib0240","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.rvsc.2020.08.007","article-title":"The inhibitory effect of canine interferon gamma on the growth of canine tumors","volume":"132","author":"Hamamura","year":"2020","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0245","first-page":"1340","article-title":"Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega","volume":"21","author":"Hampel","year":"2007","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2021.105648_bib0250","first-page":"4749","article-title":"Pro-apoptotic and growth-inhibitory effect of IFN-beta-overexpressing canine adipose tissue-derived mesenchymal stem cells against melanoma cells","volume":"35","author":"Han","year":"2015","journal-title":"Anticancer Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0255","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-2427(98)00161-5","article-title":"Treatment of feline leukemia virus-infected cats with paramunity inducer","volume":"65","author":"Hartmann","year":"1998","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0260","doi-asserted-by":"crossref","unstructured":"Hartmann, K., Day, M.J., Thiry, E., Lloret, A., Frymus, T., Addie, D., Boucraut-Baralon, C., Egberink, H., Gruffydd-Jones, T., Horzinek, M.C., et al., European Advisory Board on Cat Diseases, 2015. Feline injection-site sarcoma: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 17, 606-613.","DOI":"10.1177\/1098612X15588451"},{"key":"10.1016\/j.tvjl.2021.105648_bib0265","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1093\/nar\/13.13.4739","article-title":"A novel class of human type I interferons","volume":"13","author":"Hauptmann","year":"1985","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0270","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/vr.156.21.669","article-title":"Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries","volume":"156","author":"Helps","year":"2005","journal-title":"Veterinary Record"},{"key":"10.1016\/j.tvjl.2021.105648_bib0275","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jfms.2011.05.012","article-title":"Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: a randomised, multi-centre, controlled, double-blind study in 39 cats","volume":"13","author":"Hennet","year":"2011","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2021.105648_bib0280","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/jir.1987.7.173","article-title":"Structure and expression in Escherichia coli of canine interferon-alpha genes","volume":"7","author":"Himmler","year":"1987","journal-title":"Journal of Interferon Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0285","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jfms.2009.05.006","article-title":"Feline immunodeficiency. ABCD guidelines on prevention and management","volume":"11","author":"Hosie","year":"2009","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2021.105648_bib0290","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","article-title":"Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.tvjl.2021.105648_bib0295","first-page":"5","article-title":"Equine PBMC cytokines profile after in vitro alpha- and gamma-EHV Infection: efficacy of a Parapoxvirus ovis based-immunomodulator treatment","author":"Hue","year":"2017","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.tvjl.2021.105648_bib0300","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jfms.2003.08.011","article-title":"Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis","volume":"6","author":"Ishida","year":"2004","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2021.105648_bib0305","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1292\/jvms.60.911","article-title":"Clinical effects of the recombinant feline interferon-omega on experimental parvovirus infection in Beagle dogs","volume":"60","author":"Ishiwata","year":"1998","journal-title":"The Journal of Veterinary Medical Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0310","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1292\/jvms.09-0201","article-title":"Ability of orally administered IFN-alpha4 to inhibit naturally occurring gingival inflammation in dogs","volume":"72","author":"Ito","year":"2010","journal-title":"The Journal of Veterinary Medical Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0315","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-3164.2006.00519.x","article-title":"A randomized comparative clinical trial of recombinant canine interferon-gamma (KT-100) in atopic dogs using antihistamine as control","volume":"17","author":"Iwasaki","year":"2006","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0320","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0166-3542(83)90033-5","article-title":"Inhibition of feline leukemia virus replication by human leukocyte interferon","volume":"3","author":"Jameson","year":"1983","journal-title":"Antiviral Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0325","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/vms3.119","article-title":"Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour","volume":"4","author":"Kanca","year":"2018","journal-title":"Veterinary Medicine and Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0330","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1439-0442.1996.tb00493.x","article-title":"Effects of human interferons and 60cobalt radiation on canine and feline tumour cells-preclinical studies","volume":"43","author":"Kessler","year":"1996","journal-title":"Zentralblatt f\u00fcr Veterin\u00e4rmedizin A"},{"key":"10.1016\/j.tvjl.2021.105648_bib0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192198","article-title":"Long-term effects of canine parvovirus infection in dogs","volume":"13","author":"Kilian","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.tvjl.2021.105648_bib0340","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.vetimm.2017.08.006","article-title":"Type I interferons in the pathogenesis and treatment of canine diseases","volume":"191","author":"Klotz","year":"2017","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0345","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-2427(88)90106-7","article-title":"The effects of human interferon-alpha upon in vitro canine immune responses","volume":"19","author":"Krakowka","year":"1988","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0350","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1126\/science.169.3951.1213","article-title":"Tilorone hydrochloride: an orally active antiviral agent","volume":"169","author":"Krueger","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0355","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/jir.1994.14.57","article-title":"Cross-species antiviral and antiproliferative activity of human interferon-omega","volume":"14","author":"Kubes","year":"1994","journal-title":"Journal of Interferon Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0360","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1348-0421.2006.tb03828.x","article-title":"Immunological effects of recombinant feline interferon-omega (KT-80) administration in the dog","volume":"50","author":"Kuwabara","year":"2006","journal-title":"Microbiology and Immunology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0365","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2046-0481-66-19","article-title":"The use of oral recombinant feline interferon omega in two cats with type II diabetes mellitus and concurrent feline chronic gingivostomatitis syndrome","volume":"66","author":"Leal","year":"2013","journal-title":"Irish Veterinary Journal"},{"key":"10.1016\/j.tvjl.2021.105648_bib0370","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.rvsc.2015.02.008","article-title":"Evaluation of viremia, proviral load and cytokine profile in naturally feline immunodeficiency virus infected cats treated with two different protocols of recombinant feline interferon omega","volume":"99","author":"Leal","year":"2015","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0375","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The dual nature of type I and type II interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0380","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.intimp.2017.08.028","article-title":"Interferon-omega: current status in clinical applications","volume":"52","author":"Li","year":"2017","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0385","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cyto.2013.12.001","article-title":"Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega","volume":"66","author":"Litzlbauer","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.tvjl.2021.105648_bib0390","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jfms.2009.05.005","article-title":"Feline leukaemia. ABCD guidelines on prevention and management","volume":"11","author":"Lutz","year":"2009","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2021.105648_bib0395","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-1135(02)00173-6","article-title":"Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial","volume":"89","author":"Martin","year":"2002","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0400","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.rvsc.2018.10.003","article-title":"Evaluation of the efficacy of the subcutaneous low recombinant feline interferon-omega administration protocol for feline chronic gingivitis-stomatitis in feline calicivirus-positive cats","volume":"121","author":"Matsumoto","year":"2018","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0405","first-page":"359","article-title":"Experiences in the paraimmunization of cats in veterinary practice","volume":"12","author":"Mayr-Bibrack","year":"1984","journal-title":"Tier\u00e4rztliche Praxis"},{"key":"10.1016\/j.tvjl.2021.105648_bib0410","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5326\/15473317-37-4-356","article-title":"Immunomodulation therapy for feline leukemia virus infection","volume":"37","author":"McCaw","year":"2001","journal-title":"Journal of the American Animal Hospital Association"},{"key":"10.1016\/j.tvjl.2021.105648_bib0415","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1177\/1098612X15583344","article-title":"Pulmonary cowpox in cats: five cases","volume":"18","author":"McInerney","year":"2016","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2021.105648_bib0420","article-title":"A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis","volume":"27","author":"Michels","year":"2016","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0425","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-1135(99)00087-5","article-title":"Feline interferon-omega treatment on canine parvovirus infection","volume":"69","author":"Minagawa","year":"1999","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0430","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0378-1135(94)90095-7","article-title":"Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro","volume":"39","author":"Mochizuki","year":"1994","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0435","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1053\/rvsc.1998.0218","article-title":"In-vitro anti-proliferative effects of some anti-tumour drugs on feline mammary tumour cell lines","volume":"66","author":"Muleya","year":"1999","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0440","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1271\/bbb.56.211","article-title":"Molecular cloning of feline interferon cDNA by direct expression","volume":"56","author":"Nakamura","year":"1992","journal-title":"Bioscience, Biotechnolology and Biochemistry"},{"key":"10.1016\/j.tvjl.2021.105648_bib0445","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-3164.2009.00784.x","article-title":"Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials","volume":"21","author":"Olivry","year":"2010","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0450","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12917-015-0514-6","article-title":"Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA)","volume":"11","author":"Olivry","year":"2015","journal-title":"BMC Veterinary Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0455","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.vetmic.2014.07.015","article-title":"Efficacy of a Parapoxvirus ovis-based immunomodulator against equine herpesvirus type 1 and Streptococcus equi equi infections in horses","volume":"173","author":"Ons","year":"2014","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0460","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.vetimm.2007.04.007","article-title":"Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-omega administration","volume":"118","author":"Paltrinieri","year":"2007","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0465","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.vetimm.2005.08.020","article-title":"Low-dose interferon-alpha treatment for feline immunodeficiency virus infection","volume":"109","author":"Pedretti","year":"2006","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0470","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/icb.2010.78","article-title":"Activating and inhibitory receptors of natural killer cells","volume":"89","author":"Pegram","year":"2011","journal-title":"Immunology and Cell Biology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0475","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1476-5829.2009.00192.x","article-title":"Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours","volume":"7","author":"Penzo","year":"2009","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0480","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00239-006-0073-3","article-title":"The mammalian 2\u2019-5\u2019 oligoadenylate synthetase gene family: evidence for concerted evolution of paralogous Oas1 genes in Rodentia and Artiodactyla","volume":"63","author":"Perelygin","year":"2006","journal-title":"Journal of Molecular Evolution"},{"key":"10.1016\/j.tvjl.2021.105648_bib0485","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1098612X14560099","article-title":"Periodontal disease in cats: back to basics--with an eye on the future","volume":"17","author":"Perry","year":"2015","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2021.105648_bib0490","first-page":"93","article-title":"Feline respiratory infections\u2014a clinical review","volume":"17","author":"Povey","year":"1976","journal-title":"Canadian Veterinary Journal"},{"key":"10.1016\/j.tvjl.2021.105648_bib0495","first-page":"1193","article-title":"Effect of feline interferon-omega on the survival time and quality of life of cats with feline infectious peritonitis","volume":"21","author":"Ritz","year":"2007","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2021.105648_bib0500","first-page":"270","article-title":"Cat interferon inhibits feline leukaemia virus infection in cell culture","volume":"237","author":"Rogers","year":"1972","journal-title":"Nature: New Biology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0505","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biopha.2015.04.002","article-title":"Interferon-beta gene transfer induces a strong cytotoxic bystander effect on melanoma cells","volume":"72","author":"Rossi","year":"2015","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"10.1016\/j.tvjl.2021.105648_bib0510","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1748-5827.2006.00185.x","article-title":"Canine keratoconjunctivitis sicca: disease trends in a review of 229 cases","volume":"48","author":"Sanchez","year":"2007","journal-title":"Journal of Small Animal Practice"},{"key":"10.1016\/j.tvjl.2021.105648_bib0515","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2460\/ajvr.2005.66.210","article-title":"Effects of interferon-alpha on cytopathic changes and titers for feline herpesvirus-1 in primary cultures of feline corneal epithelial cells","volume":"66","author":"Sandmeyer","year":"2005","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0520","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semcdb.2008.08.010","article-title":"Inteferons pen the JAK-STAT pathway","volume":"19","author":"Schindler","year":"2008","journal-title":"Seminars in Cell and Develpmental Biology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0525","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Current Opinion in Virology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0530","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/1098612X15569615","article-title":"Sampling sites for detection of feline herpesvirus-1, feline calicivirus and Chlamydia felis in cats with feline upper respiratory tract disease","volume":"17","author":"Schulz","year":"2015","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2021.105648_bib0535","doi-asserted-by":"crossref","first-page":"e1534","DOI":"10.1002\/wrna.1534","article-title":"RNA regulation of the antiviral protein 2\u2019-5\u2019-oligoadenylate synthetase","volume":"10","author":"Schwartz","year":"2019","journal-title":"Wiley Interdisciplinary Reviews RNA"},{"key":"10.1016\/j.tvjl.2021.105648_bib0540","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1358\/dot.2018.54.3.2788019","article-title":"Rheumatoid arthritis: new monoclonal antibodies","volume":"54","author":"Serio","year":"2018","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.tvjl.2021.105648_bib0545","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2460\/ajvr.67.8.1406","article-title":"Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1","volume":"67","author":"Siebeck","year":"2006","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0550","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2460\/ajvr.74.2.281","article-title":"Effects of topical ocular administration of high doses of human recombinant interferon alpha-2b and feline recombinant interferon omega on naturally occurring viral keratoconjunctivitis in cats","volume":"74","author":"Slack","year":"2013","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0555","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1748-5827.2006.00166.x","article-title":"Treatment of a case of refractory feline chronic gingivostomatitis with feline recombinant interferon omega","volume":"48","author":"Southerden","year":"2007","journal-title":"Journal of Small Animal Practice"},{"key":"10.1016\/j.tvjl.2021.105648_bib0560","doi-asserted-by":"crossref","DOI":"10.1111\/vde.12682","article-title":"A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA","volume":"29","author":"Souza","year":"2018","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0565","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5326\/0400411","article-title":"Pigmented epidermal plaques in three dogs","volume":"40","author":"Stokking","year":"2004","journal-title":"Journal of the American Animal Hospital Association"},{"key":"10.1016\/j.tvjl.2021.105648_bib0570","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/1098612X12473468","article-title":"A trial with 3\u2019-azido-2\u2019,3\u2019-dideoxythymidine and human interferon-alpha in cats naturally infected with feline leukaemia virus","volume":"15","author":"Stuetzer","year":"2013","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2021.105648_bib0575","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/107999001317205169","article-title":"Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma","volume":"21","author":"Tanabe","year":"2001","journal-title":"Journal of Interferon and Cytokine Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0580","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0034-5288(95)90017-9","article-title":"In vitro growth inhibition activities of recombinant feline interferon on all lines derived from canine tumours","volume":"59","author":"Tateyama","year":"1995","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0585","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13075-019-1879-x","volume":"21","author":"Taylor","year":"2019","journal-title":"Arthritis Research and Therapy"},{"key":"10.1016\/j.tvjl.2021.105648_bib0590","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/jir.1997.17.327","article-title":"A comparison of the antiproliferative properties of recombinant human IFN-alpha 2 and IFN-omega in human bone marrow culture","volume":"17","author":"Tiefenthaler","year":"1997","journal-title":"Journal of Interferon and Cytokine Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0595","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/107999099314298","article-title":"Oromucosal interferon therapy: marked antiviral and antitumor activity","volume":"19","author":"Tovey","year":"1997","journal-title":"Journal of Interferon and Cytokine Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0600","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5326\/0440276","article-title":"Use of recombinant human interferon alpha-2a in the management of a dog with epitheliotropic lymphoma","volume":"44","author":"Tzannes","year":"2008","journal-title":"Journal of the American Animal Hospital Association"},{"key":"10.1016\/j.tvjl.2021.105648_bib0605","first-page":"7","article-title":"A large-scale field study of feline interferon on feline calicivirus infection","volume":"18","author":"Uchino","year":"1999","journal-title":"Japanese Journal of Small Animal Practice"},{"key":"10.1016\/j.tvjl.2021.105648_bib0610","series-title":"Proceedings of the International Veterinary Ophthalmology Meeting","first-page":"427","article-title":"Topical application of feline interferon omega in the treatment of herpetic keratitis in the cat: preliminary study","author":"Verneuil","year":"2004"},{"key":"10.1016\/j.tvjl.2021.105648_bib0615","first-page":"1556","article-title":"Comparison of antiviral activity between FeIFN-omega and FeIFN-alpha","volume":"24","author":"Wang","year":"2008","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"10.1016\/j.tvjl.2021.105648_bib0620","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/v12030335","article-title":"Cloning, prokaryotic soluble expression, and analysis of antiviral activity of two novel feline IFN-omega proteins","volume":"12","author":"Wang","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.tvjl.2021.105648_bib0625","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.2460\/ajvr.1989.50.10.1672","article-title":"Synergistic antiviral activities of acyclovir and recombinant human leukocyte (alpha) interferon on feline herpesvirus replication","volume":"50","author":"Weiss","year":"1989","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0630","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0378-1135(89)90049-7","article-title":"Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro","volume":"20","author":"Weiss","year":"1989","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0635","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2460\/ajvr.1990.51.05.726","article-title":"Effect of interferon or Propionibacterium acnes on the course of experimentally induced feline infectious peritonitis in specific-pathogen-free and random-source cats","volume":"51","author":"Weiss","year":"1990","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0640","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.2460\/javma.1991.199.10.1477","article-title":"Low-dose orally administered alpha interferon treatment for feline leukemia virus infection","volume":"199","author":"Weiss","year":"1991","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2021.105648_bib0645","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/avj.12781","article-title":"Diagnosing feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) infection: an update for clinicians","volume":"97","author":"Westman","year":"2019","journal-title":"Australian Veterinary Journal"},{"key":"10.1016\/j.tvjl.2021.105648_bib0650","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00007890-197608000-00018","article-title":"Prolonged survival of canine renal allografts by Tilorone","volume":"22","author":"Wildstein","year":"1976","journal-title":"Transplantation"},{"key":"10.1016\/j.tvjl.2021.105648_bib0655","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tvjl.2012.07.004","article-title":"Feline leukaemia virus: half a century since its discovery","volume":"195","author":"Willett","year":"2013","journal-title":"The Veterinary Journal"},{"key":"10.1016\/j.tvjl.2021.105648_bib0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105841","article-title":"Treatment of plaque psoriasis with IL-23p19 blockers: a systematic review and meta-analysis","volume":"75","author":"Xu","year":"2019","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0665","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1292\/jvms.19-0187","article-title":"Long-term follow-up study after administration of a canine interferon-alpha preparation for feline gingivitis","volume":"82","author":"Yamaki","year":"2020","journal-title":"The Journal of Veterinary Medical Science"},{"key":"10.1016\/j.tvjl.2021.105648_bib0670","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/jir.2013.0037","article-title":"Molecular and functional characterization of canine interferon-epsilon","volume":"33","author":"Yang","year":"2013","journal-title":"Journal of Interferon and Cytokine Research"},{"key":"10.1016\/j.tvjl.2021.105648_bib0675","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-3164.2009.00764.x","article-title":"Low-dose recombinant canine interferon-gamma for treatment of canine atopic dermatitis: an open randomized comparative trial of two doses","volume":"21","author":"Yasukawa","year":"2010","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.tvjl.2021.105648_bib0680","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1128\/AAC.34.9.1749","article-title":"Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome","volume":"34","author":"Zeidner","year":"1990","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2021.105648_bib0685","first-page":"787","article-title":"Zidovudine in combination with alpha interferon and interleukin-2 as prophylactic therapy for FeLV-induced immunodeficiency syndrome (FeLV-FAIDS)","volume":"3","author":"Zeidner","year":"1990","journal-title":"Journal of Acquired Immune Deficiency Syndromes"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023321000435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023321000435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:31:30Z","timestamp":1761071490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023321000435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":137,"alternative-id":["S1090023321000435"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2021.105648","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon therapies in small animals","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2021.105648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105648"}}